4-Chloro-4'-Biphenyl-Epi-Vancosamine - Request Quote
4-Chloro-4'-Biphenyl-Epi-Vancosamine
| SZ CAT No: | SZ-O026019 |
| CAS No | NA |
| Mol.F. | C20H24ClNO3 |
| Mol.Wt. | 361.9 |
| Inv. Status | Synthesis on demand |
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
4-Chloro-4'-Biphenyl-Epi-Vancosamine is chemically . 4-Chloro-4'-Biphenyl-Epi-Vancosamine is supplied with detailed characterization data compliant with regulatory guideline. 4-Chloro-4'-Biphenyl-Epi-Vancosamine can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oritavancin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality 4-Chloro-4'-Biphenyl-Epi-Vancosamine
Purchase 4-Chloro-4'-Biphenyl-Epi-Vancosamine
4-Chloro-4'-Biphenyl-Epi-Vancosamine suppliers
4-Chloro-4'-Biphenyl-Epi-Vancosamine manufacturers
4-Chloro-4'-Biphenyl-Epi-Vancosamine price
Order 4-Chloro-4'-Biphenyl-Epi-Vancosamine
Enquire 4-Chloro-4'-Biphenyl-Epi-Vancosamine
4-Chloro-4'-Biphenyl-Epi-Vancosamine cost
4-Chloro-4'-Biphenyl-Epi-Vancosamine Supplier
4-Chloro-4'-Biphenyl-Epi-Vancosamine Distributor
4-Chloro-4'-Biphenyl-Epi-Vancosamine for Method Validation
Oritavancin Reference Standard
4-Chloro-4'-Biphenyl-Epi-Vancosamine for ANDA Filing
4-Chloro-4'-Biphenyl-Epi-Vancosamine for Forced Degradation Studies
4-Chloro-4'-Biphenyl-Epi-Vancosamine Identification Standards
4-Chloro-4'-Biphenyl-Epi-Vancosamine for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


